Hydroxychloroquine Administration for Reduction of Pexophagy

Key facts

Sponsor

The Hospital for Sick Children

Principal Investigator

Neal Sondheimer, MD

The Hospital for Sick Children

Intervention

Hydroxychloroquine(drug)

Enrollment

3 enrolled

Eligibility

40 years · All sexes

Timeline

2019 – 2020

Study locations (1)

• The Hospital for Sick Children, Toronto, Ontario, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Zellweger syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06190626
  Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
  McGill University Health Centre/Research Institute of the McGill University Health Centre

See all trials for Zellweger syndrome →